M-A | Inibidores do SGLT-2 e desfechos cardiovasculares em pacientes com e sem histórico de insuficiência cardíaca.
31 Jan, 2022 | 08:28h
Comentário no Twitter
SGLT-2 inhibitors improve CV outcomes irrespective of heart failure history and LVEF: a meta-analysis of RCTs https://t.co/QPRCzT9olH#EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava pic.twitter.com/sESFn7Fdxg
— European Society of Cardiology Journals (@ESC_Journals) January 29, 2022